$Icecure Medical (ICCM.US)$ IceCure Medical () has received ...
$Icecure Medical (ICCM.US)$ IceCure Medical () has received a Notice of Allowance for its invention titled “Cryogenic System Connector” from the USPTO. This is the first global patent issued for the cryogenic system connector, a key component of IceCure’s next-generation liquid nitrogen-based XSense cryoablation system. Several other patent applications for this technology are pending in key markets. XSense and its cryoprobes, which have FDA clearance for all of the indications for which IceCure’s flagship ProSense has already received clearance, has the potential to address additional indications and significant unmet needs in the global tumor ablation market, estimated at $1.67B in 2023 according to Grand View Research.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
aspiring Lark_7123 : This is going to fly now.